olmesartan medoxomil
CS0866-C-J201
Phase 2 small_molecule completed
Quick answer
olmesartan medoxomil for Chronic Glomerulonephritis is a Phase 2 program (small_molecule) at Daiichi Sankyo with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Daiichi Sankyo
- Indication
- Chronic Glomerulonephritis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed